H-Thr-NHMe

H-Thr-NHMe is an N-methylated threonine amide that retains the threonine side chain with a stereogenic center at the alpha carbon, pairing an amino acid backbone with an amide-forming functionality at the C-terminus. The structure features a primary hydroxyl group on the side chain and an N-methylamide motif (H-Thr-NHMe) that modulates hydrogen-bonding, polarity, and peptide-coupling behavior relative to free amino acids. The presence of the hydroxyl enables selective derivatization or protection strategies, while the amide nitrogen can participate in acylation chemistry under peptide-synthesis compatible conditions. As a chiral amino acid derivative, H-Thr-NHMe functions as a compact intermediate for building peptide fragments, preparing N-methylated residues, and generating downstream threonine-based analogs for biochemical and synthetic organic workflows.

1. Peptide Synthesis

H-Thr-NHMe is used in peptide synthesis planning as an N-methylated threonine building block where the amide end can be carried through fragment assembly without requiring conversion to a free carboxylic acid. The threonine alpha stereocenter and side-chain hydroxyl provide defined stereochemical and functional-group handles for controlled coupling and subsequent side-chain modification. Incorporation of the N-methylamide character can support the preparation of backbone-modified peptides and peptide fragments that require reduced terminal basicity and altered hydrogen-bond donors. Downstream peptide analog construction can proceed via side-chain hydroxyl protection/deprotection and standard peptide coupling logic, enabling systematic evaluation of threonine residue effects in synthetic peptide libraries.

2. Chemical Biology

H-Thr-NHMe is applicable to chemical biology research where threonine-derived, N-methylated amide motifs serve as defined recognition elements in small-molecule probes and peptide-like ligands. The side-chain hydroxyl can be functionalized to introduce handles for conjugation chemistry, such as electrophile-compatible derivatization or orthogonally protected alcohol strategies, while the chiral center preserves stereochemical fidelity for structure-function studies. The N-methylamide portion can reduce conformational freedom and tune amide hydrogen-bonding patterns, which may be leveraged when designing probe scaffolds for protein-binding assays or enzyme-interaction studies. Resulting derivatives can be used as biochemical research intermediates for molecular recognition investigations and for mapping how threonine hydroxyl chemistry influences binding or processing.

3. Amino Acid Derivatization

H-Thr-NHMe supports amino acid derivatization workflows that target the side-chain hydroxyl for selective transformation while maintaining the chiral threonine backbone. The primary alcohol can be converted into protected ethers/esters or activated derivatives that enable subsequent substitution, oxidation, or incorporation into larger functional frameworks. The N-methylamide provides a stable, non-carboxylic acid terminus that can be carried as a fragment during multi-step synthesis, including preparation of threonine-based analogs where the terminal amide is retained. Downstream utility includes generating stereochemically defined intermediates for peptidomimetic construction, scaffold diversification, and process-oriented fine chemical synthesis of threonine-functional derivatives.

4. Chiral Building Block Development

H-Thr-NHMe is suitable for chiral building block development in synthetic organic chemistry due to the preserved threonine stereocenter and the presence of orthogonally addressable functional groups. The combination of a chiral alpha carbon, a side-chain hydroxyl, and an N-methylamide allows chemists to design stereocontrolled sequences where alcohol protection and amide-stable manipulations can be coordinated. The N-methylamide can serve as a persistent structural element when preparing N-methylated peptide residues or when constructing constrained peptide-like backbones. Downstream formation of chiral threonine analogs can feed into SAR studies, fragment-based molecular design, and stereochemical mapping of how threonine residue geometry and hydroxyl reactivity affect target interactions.

5. Pharmaceutical Manufacturing

H-Thr-NHMe can be employed in pharmaceutical manufacturing contexts as a controlled intermediate for producing N-methylated threonine-containing fragments used in peptide or peptide-inspired ingredient synthesis. The amide functionality and N-methyl substitution support manufacturing route design where a defined residue is introduced without requiring late-stage conversion from a free acid, reducing variability in terminal functional group handling. The side-chain hydroxyl can be protected early to manage chemoselectivity during fragment coupling or subsequent transformations, aligning with typical process chemistry strategies for multi-functional amino acid derivatives. Downstream applications include preparation of standardized building blocks for controlled assembly of peptide-like structures and for generating consistent analytical reference materials tied to threonine-based intermediates.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma